Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 18, 2022 06:00 ET | Source: Bionomics Ltd

Bionomics Receives R&D Tax Incentive Refund for FY2022 of A$4.6 million

ADELAIDE, Australia, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical stage biopharmaceutical company, is pleased to announce that the...
October 04, 2022 06:00 ET | Source: Bionomics Ltd

Bionomics Limited to Participate in the Cantor Neurology & Psychiatry Conference

ADELAIDE, Australia, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
September 21, 2022 06:00 ET | Source: Bionomics Ltd

Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder

ADELAIDE, Australia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO, Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
August 31, 2022 06:00 ET | Source: Bionomics Ltd

Bionomics to Participate in Upcoming September Investor Conferences

ADELAIDE, Australia, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
August 25, 2022 06:00 ET | Source: Bionomics Ltd

Bionomics reports Full Year Financial Results

ADELAIDE, Australia, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX:BNO, Nasdaq:BNOX), today announced its financial results for the 12 months ended 30 June 2022. Bionomics is a clinical...
August 08, 2022 06:00 ET | Source: Bionomics Ltd

Bionomics Receives R&D Tax Incentive Refund for FY2021 of A$2.1M

ADELAIDE, Australia, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, NASDAQ:BNOX), a clinical stage biopharmaceutical company, is pleased to announce that the Company has received...
July 29, 2022 06:00 ET | Source: Bionomics Ltd

Quarterly Activities Report for June 2022

ADELAIDE, Australia, July 29, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a global, clinical stage biopharmaceutical company, today released its...
July 08, 2022 06:00 ET | Source: Bionomics Ltd

Bionomics to Participate in William Blair’s Biotech Focus Conference 2022

ADELAIDE, Australia, July 08, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
June 27, 2022 06:00 ET | Source: Bionomics Ltd

Bionomics Limited to Participate in the H.C. Wainwright Mental Health Conference

ADELAIDE, Australia, June 27, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion...
June 13, 2022 16:30 ET | Source: Bionomics Ltd

Bionomics Investor Webinar

ADELAIDE, Australia, June 13, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO |Nasdaq: BNOX ), (Bionomics or the Company), a clinical-stage biopharmaceutical company developing novel,...